Peter Kies
Vermögen: 56 630 $ am 31.05.2026
Vermögen: 56 630 $ am 31.05.2026
Peter D.
Kies is currently the Chief Financial Officer at Inovio Pharmaceuticals, Inc., a position held since 2002.
Formerly, Mr. Kies was Chief Financial Officer at Newgen Results Corp.
from 1996 to 2002.
Other former roles include Chief Financial Officer at Genetronics Biomedical Corp., Auditor at Ernst & Young LLP, and Controller at Cytel Corp.
Education includes undergraduate studies at Alliant International University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.05.2026 | 43 229 ( 0,05 % ) | 56 630 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.06.2002 |
| Unternehmen | Position | Ende |
|---|---|---|
Genetronics Biomedical Corp.
Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Finanzdirektor/CFO | 05.04.2005 |
Newgen Results Corp.
Newgen Results Corp. Advertising/Marketing ServicesCommercial Services Provides customer relationship and database management services | Finanzdirektor/CFO | 01.06.2002 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | - |
Cytel Corp. | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Newgen Results Corp.
Newgen Results Corp. Advertising/Marketing ServicesCommercial Services Provides customer relationship and database management services | Commercial Services |
Genetronics Biomedical Corp.
Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Commercial Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Alliant International University
Alliant International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Cytel Corp. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen